Review



b16f10luc2 cells  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 95
      Buy from Supplier

    Structured Review

    ATCC b16f10luc2 cells
    B16f10luc2 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 52 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/b16f10luc2+cells/pm30408617-184-6-8?v=ATCC
    Average 95 stars, based on 52 article reviews
    b16f10luc2 cells - by Bioz Stars, 2026-08
    95/100 stars

    Images



    Similar Products

    b16f10luc2 cells  (ATCC)
    95
    ATCC b16f10luc2 cells
    B16f10luc2 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/b16f10luc2+cells/pm30408617-184-6-8?v=ATCC
    Average 95 stars, based on 1 article reviews
    b16f10luc2 cells - by Bioz Stars, 2026-08
    95/100 stars
    		  Buy from Supplier
    b16f10luc2 melanoma cells  (Thermo Fisher)
    90
    Thermo Fisher b16f10luc2 melanoma cells
    B16f10luc2 Melanoma Cells, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/b16f10luc2+cells/pm28104440-103-0-3?v=Thermo+Fisher
    Average 90 stars, based on 1 article reviews
    b16f10luc2 melanoma cells - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    b16f10luc2 melanoma cells  (ATCC)
    95
    ATCC b16f10luc2 melanoma cells
    Addition of licofelone to a long-peptide cancer vaccine therapy prolongs survival of melanoma-bearing mice . Groups of mice ( n = 7) were injected s.c. with 5 × 10 4 <t>B16F10luc2</t> tumor cells and were subsequently left untreated or injected i.v. on day 6 with TRP2-peptide and α-GalCer in cationic liposomes or TRP2-peptide, α-GalCer, and licofelone in cationic liposomes. Mice that received a vaccine containing licofelone in cationic liposomes were also injected s.c. every second day with the licofelone formulated into cationic liposomes while a control group of mice received only s.c. injections of licofelone liposomes. The graph shows the Kaplan–Meier survival curve. Data are representative of two independent experiments with each n = 7 mice/group, *** p < 0.0001.
    B16f10luc2 Melanoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/b16f10luc2+cells/pmc05137024-48-0-6?v=ATCC
    Average 95 stars, based on 1 article reviews
    b16f10luc2 melanoma cells - by Bioz Stars, 2026-08
    95/100 stars
    		  Buy from Supplier

    Image Search Results


    Addition of licofelone to a long-peptide cancer vaccine therapy prolongs survival of melanoma-bearing mice . Groups of mice ( n = 7) were injected s.c. with 5 × 10 4 B16F10luc2 tumor cells and were subsequently left untreated or injected i.v. on day 6 with TRP2-peptide and α-GalCer in cationic liposomes or TRP2-peptide, α-GalCer, and licofelone in cationic liposomes. Mice that received a vaccine containing licofelone in cationic liposomes were also injected s.c. every second day with the licofelone formulated into cationic liposomes while a control group of mice received only s.c. injections of licofelone liposomes. The graph shows the Kaplan–Meier survival curve. Data are representative of two independent experiments with each n = 7 mice/group, *** p < 0.0001.

    Journal: Frontiers in Immunology

    Article Title: Improved Antitumor Activity of a Therapeutic Melanoma Vaccine through the Use of the Dual COX-2/5-LO Inhibitor Licofelone

    doi: 10.3389/fimmu.2016.00537

    Figure Lengend Snippet: Addition of licofelone to a long-peptide cancer vaccine therapy prolongs survival of melanoma-bearing mice . Groups of mice ( n = 7) were injected s.c. with 5 × 10 4 B16F10luc2 tumor cells and were subsequently left untreated or injected i.v. on day 6 with TRP2-peptide and α-GalCer in cationic liposomes or TRP2-peptide, α-GalCer, and licofelone in cationic liposomes. Mice that received a vaccine containing licofelone in cationic liposomes were also injected s.c. every second day with the licofelone formulated into cationic liposomes while a control group of mice received only s.c. injections of licofelone liposomes. The graph shows the Kaplan–Meier survival curve. Data are representative of two independent experiments with each n = 7 mice/group, *** p < 0.0001.

    Article Snippet: B16F10luc2 melanoma cells were obtained from ATCC, New Zealand.

    Techniques: Injection, Liposomes, Control

    Viability (A) and ROS production (B) of melanoma cells derived ex vivo are not changed by licofelone treatment . B16F10luc2 melanoma cells were treated with licofelone at 1, 5, 10, or 20 μM for 48 h. Data shown are the mean + SD from three individual experiments.

    Journal: Frontiers in Immunology

    Article Title: Improved Antitumor Activity of a Therapeutic Melanoma Vaccine through the Use of the Dual COX-2/5-LO Inhibitor Licofelone

    doi: 10.3389/fimmu.2016.00537

    Figure Lengend Snippet: Viability (A) and ROS production (B) of melanoma cells derived ex vivo are not changed by licofelone treatment . B16F10luc2 melanoma cells were treated with licofelone at 1, 5, 10, or 20 μM for 48 h. Data shown are the mean + SD from three individual experiments.

    Article Snippet: B16F10luc2 melanoma cells were obtained from ATCC, New Zealand.

    Techniques: Derivative Assay, Ex Vivo